In the phase 2 trial, efficacy was also seen in patients with non-atopic chronic hand eczema treated with the oral JAK ...

Chronic hand eczema is a type of skin disease that affects the skin on your hands and wrists. While there is no cure for chronic hand eczema, different types of medicines can be used to help manage ...

Anzupgo (delgocitinib) is the first and only topical medication specifically approved for adults with moderate to severe chronic hand eczema. In large clinical trials, the cream significantly improved ...

Delgocitinib vs PUVA shows comparable efficacy in chronic hand eczema with QoL benefits. Find out more about this real-world study.

Treatment with abrocitinib, an oral JAK1 inhibitor, led to substantial improvements in the signs and symptoms of chronic hand ...

Using proprietary real-world patient data and an early validated drug candidate, Analgesia.ai is building an AI-powered ...

Almost everyone has pain sometimes. It might start as a twinge in your back, a dull ache in your knee, a tingling on the bottoms of your feet. Maybe you slept funny, or hoisted a full bag of groceries ...

Chronic pain is remarkably common: Roughly 20% of adults in the US live with it. And people with chronic pain are more likely to have depression, anxiety, and substance abuse disorders. But this ...

The newly FDA-approved treatment Anzupgo (delgocitinib) could offer steroid-free relief for people living with intensely dry, itchy, painful skin. Anzupgo (delgocitinib) is the first and only topical ...